| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pulmonary_hypertension_association [2023/04/17 01:42]
liam | pulmonary_hypertension_association [2023/04/17 02:16] (current)
liam [Corporate committee] |
|---|
| ==== Funding ==== | ==== Funding ==== |
| |
| PHA's sponsors and donors include:((Wetherill, J. //Sponsors.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416215850/https://phassociation.org/aboutpha/sponsors/)) ((Wetherill, J. //Annual Report - 2021.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416223004/https://phassociation.org/accountability/annual-report-2021/)) ((Granato, M. J., & Brunetti, C. (2021, September 14). //PHA Annual Report 2020 by Pulmonary Hypertension Association.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416231442/https://issuu.com/phassociation/docs/pha-2020_annual_report_issuu_final)) ((Wong, B. A., & Fagan, K. A. (2020, August 6). //PHA 2019 Annual Report.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416232200/https://issuu.com/phassociation/docs/pha_2019_annual_report_-_pages)) | PHA's sponsors and donors include:((Wetherill, J. //Sponsors.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416215850/https://phassociation.org/aboutpha/sponsors/)) ((Wetherill, J. //Annual Report - 2021.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416223004/https://phassociation.org/accountability/annual-report-2021/)) ((Granato, M. J., & Brunetti, C. (2021, September 14). //PHA Annual Report 2020 by Pulmonary Hypertension Association.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416231442/https://issuu.com/phassociation/docs/pha-2020_annual_report_issuu_final)) ((Wong, B. A., & Fagan, K. A. (2020, August 6). //PHA 2019 Annual Report.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416232200/https://issuu.com/phassociation/docs/pha_2019_annual_report_-_pages)) ((McGoon, M. D. //Annual Report 2007.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824100439/http://www.phassociation.org/document.doc?id=47)) |
| |
| <WRAP column col4> | <WRAP column col4> |
| * [[Northside Hospital Healthcare System]] | * [[Northside Hospital Healthcare System]] |
| * [[Ontario Systems]] | * [[Ontario Systems]] |
| | * [[Oracle]] |
| * [[Order Sons of Italy in America]] | * [[Order Sons of Italy in America]] |
| * [[Penn Presbyterian Medical Center]] | * [[Penn Presbyterian Medical Center]] |
| * [[Real Estate One Charitable Foundation]] | * [[Real Estate One Charitable Foundation]] |
| * [[Robert Wood Johnson Foundation]] | * [[Robert Wood Johnson Foundation]] |
| | * [[Scleroderma Foundation]] |
| * [[sMiles for Katie]] | * [[sMiles for Katie]] |
| * [[Springer India]] | * [[Springer India]] |
| ==== Corporate committee ==== | ==== Corporate committee ==== |
| |
| [[Jim Serpico]] of [[pharmaceutical_companie:Bayer]] is chair of PHA's corporate committee. | [[Jim Serpico]] of [[pharmaceutical_companies:Bayer]] is chair of PHA's corporate committee. Committee member companies also provide funding to PHA, based on wording from earlier annual reports. |
| |
| Members include:((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416220234/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved July 1, 2017, from http://archive.today/2017.07.01-171109/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved August 20, 2019, from https://web.archive.org/web/20190820134625/https://phassociation.org/corporate-committee/)) | Members include:((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416220234/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved July 1, 2017, from http://archive.today/2017.07.01-171109/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved August 20, 2019, from https://web.archive.org/web/20190820134625/https://phassociation.org/corporate-committee/)) ((McLaughlin, V., & Aldrighetti, R. //Annual Report 2012.// Pulmonary Hypertension Association. Retrieved November 29, 2022, from https://web.archive.org/web/20221129110205/https://phassociation.org/wp-content/uploads/2017/02/PHA-Annual-Report-2012.pdf)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46)) ((Hicks, C., & Aldrighetti, R. //Annual Report 2008.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824091525/http://www.phassociation.org/document.doc?id=28)) |
| |
| <WRAP column col4> | <WRAP column col4> |
| * [[pharmaceutical_companies:Ballerophon Therapeutics]] (former) | * [[pharmaceutical_companies:Ballerophon Therapeutics]] (former) |
| * [[pharmaceutical_companies:Bayer]] | * [[pharmaceutical_companies:Bayer]] |
| | * [[pharmaceutical_companies:Biogen]] (former) |
| * [[Optum Specialty Pharmacy|BriovaRx]] (former) | * [[Optum Specialty Pharmacy|BriovaRx]] (former) |
| * [[pharmaceutical_companies:Complexa]] (former) | * [[pharmaceutical_companies:Complexa]] (former) |
| | * [[pharmaceutical_companies:CoTherix]] (former) |
| | * [[pharmaceutical_companies:CuraScript Therapeutics]] (former) |
| * [[CVS Caremark]] (former) | * [[CVS Caremark]] (former) |
| * [[CVS Specialty]] | * [[CVS Specialty]] |
| * [[pharmaceutical_companies:Eiger BioPharmaceuticals]] (former) | * [[pharmaceutical_companies:Eiger BioPharmaceuticals]] (former) |
| | * [[pharmaceutical_companies:Eli Lilly]] (former) |
| | * [[pharmaceutical_companies:Encysive Pharmaceuticals]] (former) |
| * [[pharmaceutical_companies:Enzyvant]] | * [[pharmaceutical_companies:Enzyvant]] |
| * [[pharmaceutical_companies:Gilead Sciences]] (former) | * [[pharmaceutical_companies:Gilead Sciences]] (former) |
| * [[medical_technology_companies:Medtronic]] (former) | * [[medical_technology_companies:Medtronic]] (former) |
| * [[pharmaceutical_companies:Merck]] | * [[pharmaceutical_companies:Merck]] |
| | * [[pharmaceutical_companies:Myogen]] (former) |
| | * [[pharmaceutical_companies:Novartis]] (former) |
| | * [[pharmaceutical_companies:Pfizer]] (former) |
| | * [[Pharmaceutical Research and Manufacturers of America]] (PhRMA - former) |
| * [[pharmaceutical_companies:Reata Pharmaceuticals]] (former) | * [[pharmaceutical_companies:Reata Pharmaceuticals]] (former) |
| * [[pharmaceutical_companies:Respira Therapeutics]] | * [[pharmaceutical_companies:Respira Therapeutics]] |
| * [[Shields Health Solutions]] (former) | * [[Shields Health Solutions]] (former) |
| * [[pharmaceutical_companies:SteadyMed Therapeutics]] (former) | * [[pharmaceutical_companies:SteadyMed Therapeutics]] (former) |
| | * [[pharmaceutical_companies:Teva Pharmaceuticals]] (former) |
| * [[pharmaceutical_companies:United Therapeutics]] | * [[pharmaceutical_companies:United Therapeutics]] |
| * [[Walgreens]] | * [[Walgreens]] |
